{
  "id": "map_1787",
  "title": "OSTEOPOROSIS\\NPOSMENOP√ÅUSICA",
  "specialty": "Reumatolog√≠a",
  "tag": "üìã Gu√≠a Cl√≠nica",
  "node_count": 200,
  "root": {
    "text": "OSTEOPOROSIS\\NPOSMENOP√ÅUSICA",
    "children": [
      {
        "text": "OSTEOPOROSIS\\NPOSMENOP√ÅUSICA",
        "children": []
      },
      {
        "text": "‚Ü≥ Basado en gu√≠as (1-4):",
        "children": []
      },
      {
        "text": "‚Ä¢ NOF 2008",
        "children": []
      },
      {
        "text": "‚Ä¢ ISCD 2007",
        "children": []
      },
      {
        "text": "‚Ä¢ ACP 2008",
        "children": []
      },
      {
        "text": "‚Ä¢ North American\\NMenopause Society",
        "children": []
      },
      {
        "text": "DEFINICI√ìN",
        "children": []
      },
      {
        "text": "‚Ü≥ Enfermedad ‚Üí ‚Üì\\Nresistencia esquel√©tica",
        "children": []
      },
      {
        "text": "‚Ü≥ ‚Üí ‚Üë riesgo fractura",
        "children": []
      },
      {
        "text": "CRITERIOS\\NDIAGN√ìSTICOS\\N[requiere ‚â•1]",
        "children": []
      },
      {
        "text": "1. Fractura\\Nosteopor√≥tica:",
        "children": []
      },
      {
        "text": "‚Ä¢\\NEspont√°nea/trauma\\Nbaja energ√≠a",
        "children": []
      },
      {
        "text": "‚Ä¢ Edad >40 a√±os",
        "children": []
      },
      {
        "text": "‚Ä¢ Sitios t√≠picos:\\Nv√©rtebra/cadera/antebrazo/h√∫mero/tobillo/pelvis",
        "children": []
      },
      {
        "text": "‚Ä¢ Exclusi√≥n:\\Ncara/cr√°neo/falanges/ortejos",
        "children": []
      },
      {
        "text": "2. Densitometr√≠a √≥sea\\N(DXA) anormal:",
        "children": []
      },
      {
        "text": "‚Ü≥ Criterios OMS 1994",
        "children": []
      },
      {
        "text": "‚Ü≥ Medici√≥n: columna\\Nlumbar/cuello femoral/cadera\\Ntotal",
        "children": []
      },
      {
        "text": "‚Ü≥ T-score ‚Üí\\Ncomparaci√≥n con:",
        "children": []
      },
      {
        "text": "‚Ä¢ Persona sana",
        "children": []
      },
      {
        "text": "‚Ä¢ 30 a√±os",
        "children": []
      },
      {
        "text": "‚Ä¢ Mismo sexo/etnia",
        "children": []
      },
      {
        "text": "VALORES T-SCORE",
        "children": []
      },
      {
        "text": "‚Ü≥ Normal: >-1 DS",
        "children": []
      },
      {
        "text": "‚Ü≥ Osteopenia:\\N-1 a -2.5 DS",
        "children": []
      },
      {
        "text": "‚Ü≥\\NOsteoporosis:\\N<-2.5 DS",
        "children": []
      },
      {
        "text": "‚Ü≥ Osteoporosis grave: <-2.5\\NDS + fractura fragilidad",
        "children": []
      },
      {
        "text": "FRACTURAS\\NVERTEBRALES",
        "children": []
      },
      {
        "text": "‚Ü≥ Prevalencia\\NLatinoam√©rica [Estudio\\NLAVOS]:",
        "children": []
      },
      {
        "text": "‚Ä¢ >50 a√±os: 11.8%",
        "children": []
      },
      {
        "text": "‚Ä¢ 50-59 a√±os: 8.3%",
        "children": []
      },
      {
        "text": "‚Ä¢ >80 a√±os: 37%",
        "children": []
      },
      {
        "text": "FACTORES\\NRIESGO\\NFRACTURA",
        "children": []
      },
      {
        "text": "‚Ü≥ Evaluaci√≥n: FRAX (Fracture\\NRisk Assessment Tool)",
        "children": []
      },
      {
        "text": "‚Ü≥ Predicci√≥n: riesgo\\Nfractura cadera a 10 a√±os",
        "children": []
      },
      {
        "text": "‚Ü≥ Detalles:\\Ngu√≠as NOF 2008",
        "children": []
      },
      {
        "text": "FACTORES DE RIESGO\\NOSTEOPOROSIS [Tabla 17-1]",
        "children": []
      },
      {
        "text": "‚Ü≥ Edad (>65a = ‚Üë riesgo)",
        "children": []
      },
      {
        "text": "‚Ü≥ Sexo (femenino\\N> masculino)",
        "children": []
      },
      {
        "text": "‚Ü≥ Delgadez (IMC\\N< 20 kg/m¬≤)",
        "children": []
      },
      {
        "text": "‚Ü≥ Antecedentes:",
        "children": []
      },
      {
        "text": "‚Ä¢ Personal fractura",
        "children": []
      },
      {
        "text": "‚Ä¢ Familiar\\Nfractura\\Ncaderas",
        "children": []
      },
      {
        "text": "‚Ü≥ H√°bitos:",
        "children": []
      },
      {
        "text": "‚Ä¢ Tabaquismo activo",
        "children": []
      },
      {
        "text": "‚Ä¢ Alcohol >3\\Nvasos vino/d√≠a",
        "children": []
      },
      {
        "text": "‚Ü≥ Medicamentos:",
        "children": []
      },
      {
        "text": "‚Ä¢ Glucocorticoides uso\\Nactual/reciente",
        "children": []
      },
      {
        "text": "‚Ü≥ Patolog√≠as:",
        "children": []
      },
      {
        "text": "‚Ä¢ Artritis reumatoidea",
        "children": []
      },
      {
        "text": "‚Ä¢ DM1",
        "children": []
      },
      {
        "text": "‚Ä¢ Osteog√©nesis\\Nimperfecta",
        "children": []
      },
      {
        "text": "‚Ä¢ Hipertiroidismo",
        "children": []
      },
      {
        "text": "‚Ä¢ Hipogonadismo",
        "children": []
      },
      {
        "text": "‚Ä¢ Menopausia prematura",
        "children": []
      },
      {
        "text": "‚Ä¢ Desnutrici√≥n cr√≥nica",
        "children": []
      },
      {
        "text": "‚Ä¢ Malabsorci√≥n",
        "children": []
      },
      {
        "text": "‚Ä¢ Da√±o hep√°tico cr√≥nico",
        "children": []
      },
      {
        "text": "RECOMENDACI√ìN 1:\\NINDICACIONES DXA\\NPOSMENOPAUSIA",
        "children": []
      },
      {
        "text": "‚Ü≥ Criterios:",
        "children": []
      },
      {
        "text": "1. Mujer ‚â•65 a√±os",
        "children": []
      },
      {
        "text": "2. <65 a√±os + ‚â•2\\Nfactores riesgo",
        "children": []
      },
      {
        "text": "3. Transici√≥n\\Nmenopausia +\\Nfactores:",
        "children": []
      },
      {
        "text": "‚Ä¢ Peso corporal bajo",
        "children": []
      },
      {
        "text": "‚Ä¢ Fractura previa\\Ntrauma leve",
        "children": []
      },
      {
        "text": "‚Ä¢ Medicamentos\\Nosteopenizantes",
        "children": []
      },
      {
        "text": "4. Fractura post-50 a√±os",
        "children": []
      },
      {
        "text": "5. Enfermedades/medicamentos\\N‚Üí ‚Üëp√©rdida √≥sea:",
        "children": []
      },
      {
        "text": "‚Ä¢ Hiperparatiroidismo 1¬∞",
        "children": []
      },
      {
        "text": "‚Ä¢ Prednisona\\N‚â•5mg/d√≠a (>3\\Nmeses)",
        "children": []
      },
      {
        "text": "6. Anomal√≠as vertebrales\\NRx convencional",
        "children": []
      },
      {
        "text": "7. Control\\Ntratamiento\\Nosteoporosis",
        "children": []
      },
      {
        "text": "INTERPRETACI√ìN\\NDXA",
        "children": []
      },
      {
        "text": "‚Ü≥ V√©rtebras:",
        "children": []
      },
      {
        "text": "‚Ä¢ Excluir diferencia >1\\NDS vs adyacentes",
        "children": []
      },
      {
        "text": "‚Ä¢ Usar valor\\NT-score m√°s bajo",
        "children": []
      },
      {
        "text": "‚Ü≥ DMO radio: tercio distal\\Nantebrazo no dominante",
        "children": []
      },
      {
        "text": "DMO EN RADIO\\N[Indicado si]:",
        "children": []
      },
      {
        "text": "‚Ü≥ Columna/cadera\\Nno interpretables",
        "children": []
      },
      {
        "text": "‚Ü≥ Sospecha\\Nhiperparatiroidismo\\N1¬∞",
        "children": []
      },
      {
        "text": "‚Ü≥ Obesidad\\Nsevera (>130 kg)",
        "children": []
      },
      {
        "text": "SEGUIMIENTO DMO",
        "children": []
      },
      {
        "text": "‚Ü≥ Sin terapia:",
        "children": []
      },
      {
        "text": "‚Ä¢ P√©rdida\\Nhabitual: 1-1.\\N5%/a√±o",
        "children": []
      },
      {
        "text": "‚Ä¢ Control: 2-5 a√±os",
        "children": []
      },
      {
        "text": "‚Ü≥ Con terapia:",
        "children": []
      },
      {
        "text": "‚Ä¢ Control: >2 a√±os",
        "children": []
      },
      {
        "text": "‚Ä¢ √âxito: DMO estable/‚Üë",
        "children": []
      },
      {
        "text": "‚Ä¢ Alerta: ‚ÜìDMO marcada ‚Üí\\Ninvestigar causas 2as",
        "children": []
      },
      {
        "text": "RECOMENDACI√ìN 2:\\NRX COLUMNA",
        "children": []
      },
      {
        "text": "‚Ü≥ Indicaciones:",
        "children": []
      },
      {
        "text": "‚Ä¢ P√©rdida estatura:",
        "children": []
      },
      {
        "text": "- >4 cm total",
        "children": []
      },
      {
        "text": "- >2 cm/a√±o",
        "children": []
      },
      {
        "text": "‚Ä¢ Antecedente\\Nfractura vertebral",
        "children": []
      },
      {
        "text": "‚Ä¢ DXA anormal:",
        "children": []
      },
      {
        "text": "- Anatom√≠a\\Nvertebral\\Nalterada",
        "children": []
      },
      {
        "text": "- Diferencia >1 DE\\Nentre v√©rtebras",
        "children": []
      },
      {
        "text": "‚Ä¢ Cifosis osteopor√≥tica",
        "children": []
      },
      {
        "text": "‚Ä¢ Dolor:",
        "children": []
      },
      {
        "text": "- Agudo",
        "children": []
      },
      {
        "text": "- Dorsal/lumbar\\Npersistente",
        "children": []
      },
      {
        "text": "‚Ä¢ T-score <-4",
        "children": []
      },
      {
        "text": "RECOMENDACI√ìN 3:\\NESTUDIO CAUSAS 2as",
        "children": []
      },
      {
        "text": "‚Ü≥ Prevalencia:\\N25-41% (7)",
        "children": []
      },
      {
        "text": "‚Ü≥ Estudio inicial:",
        "children": []
      },
      {
        "text": "‚Ä¢ Hemograma/VHS",
        "children": []
      },
      {
        "text": "‚Ä¢ Perfil bioqu√≠mico",
        "children": []
      },
      {
        "text": "‚Ä¢ Creatinina plasm√°tica",
        "children": []
      },
      {
        "text": "‚Ä¢ PTH",
        "children": []
      },
      {
        "text": "‚Ä¢ TSH",
        "children": []
      },
      {
        "text": "‚Ä¢ Orina 24h:",
        "children": []
      },
      {
        "text": "- Calcio",
        "children": []
      },
      {
        "text": "- Creatinina",
        "children": []
      },
      {
        "text": "[Sin suplementos\\NCa/diur√©ticos 2 sem\\Nprevias]",
        "children": []
      },
      {
        "text": "MEDIDAS GENERALES",
        "children": []
      },
      {
        "text": "‚Ü≥ Citrato calcio:",
        "children": []
      },
      {
        "text": "‚Ä¢ Indicado:\\N‚Üìacidez g√°strica",
        "children": []
      },
      {
        "text": "‚Ä¢ Escenarios:",
        "children": []
      },
      {
        "text": "- IBP/Anti-H2",
        "children": []
      },
      {
        "text": "- Gastritis atr√≥fica",
        "children": []
      },
      {
        "text": "- >60 a√±os",
        "children": []
      },
      {
        "text": "‚Ü≥ Vitamina D:",
        "children": []
      },
      {
        "text": "‚Ä¢ Funciones:",
        "children": []
      },
      {
        "text": "- Absorci√≥n Ca intestinal",
        "children": []
      },
      {
        "text": "- Salud √≥sea",
        "children": []
      },
      {
        "text": "- Funci√≥n muscular",
        "children": []
      },
      {
        "text": "‚Ä¢ Datos Chile: 60% mujeres\\Nposmenop√°usicas 25OHD <20 ng/ml (8)",
        "children": []
      },
      {
        "text": "‚Ä¢ NOF recomienda:",
        "children": []
      },
      {
        "text": "- Dosis: 800-1000 UI/d√≠a",
        "children": []
      },
      {
        "text": "- Edad: >50 a√±os",
        "children": []
      },
      {
        "text": "- Meta: 25OHD\\N>30 ng/ml",
        "children": []
      },
      {
        "text": "‚Ü≥ Otras medidas:",
        "children": []
      },
      {
        "text": "‚Ä¢ Actividad f√≠sica regular",
        "children": []
      },
      {
        "text": "‚Ä¢ Suspender tabaco",
        "children": []
      },
      {
        "text": "‚Ä¢ Limitar alcohol",
        "children": []
      },
      {
        "text": "‚Ä¢ Prevenir ca√≠das",
        "children": []
      },
      {
        "text": "RECOMENDACI√ìN 4:\\NTRATAMIENTO\\NFARMACOL√ìGICO",
        "children": []
      },
      {
        "text": "‚Ü≥ Indicaciones NOF:",
        "children": []
      },
      {
        "text": "1. Fractura osteopor√≥tica\\N(cadera/vertebral):",
        "children": []
      },
      {
        "text": "‚Ä¢ Cl√≠nica/morfom√©trica",
        "children": []
      },
      {
        "text": "‚Ä¢ Independiente DMO",
        "children": []
      },
      {
        "text": "2. Osteoporosis DXA:",
        "children": []
      },
      {
        "text": "‚Ä¢ T-score ‚â§-2.5\\N(cadera/columna)",
        "children": []
      },
      {
        "text": "‚Ä¢ Post-descarte\\Ncausas 2as",
        "children": []
      },
      {
        "text": "ELECCI√ìN\\NTRATAMIENTO [Tabla\\N17-2]",
        "children": []
      },
      {
        "text": "‚Ü≥ Factores\\Nconsideraci√≥n:",
        "children": []
      },
      {
        "text": "‚Ä¢ Riesgo fractura",
        "children": []
      },
      {
        "text": "‚Ä¢ Eficacia antifractura",
        "children": []
      },
      {
        "text": "‚Ä¢ Localizaci√≥n\\N(vertebral/perif√©rico/cadera)",
        "children": []
      },
      {
        "text": "‚Ä¢ Efectos adversos",
        "children": []
      },
      {
        "text": "‚Ä¢ Adherencia",
        "children": []
      },
      {
        "text": "‚Ä¢ Riesgo/beneficio\\Nextraesquel√©tico",
        "children": []
      },
      {
        "text": "‚Ä¢ Costo",
        "children": []
      },
      {
        "text": "‚Ü≥ Evidencia\\Nprevenci√≥n\\Nfracturas:",
        "children": []
      },
      {
        "text": "1. Antirresortivos:",
        "children": []
      },
      {
        "text": "‚Ä¢ +++:\\NAlendronato/Risedronato/Ibandronato/Zoledronato/Terapia\\Nestrog√©nica/Denosumab",
        "children": []
      },
      {
        "text": "‚Ä¢ ++: Calcitonina",
        "children": []
      },
      {
        "text": "2. Anab√≥licos:",
        "children": []
      },
      {
        "text": "‚Ä¢ PTH: +++\\Nvertebral, +\\Ncadera",
        "children": []
      },
      {
        "text": "3. Mixtos:",
        "children": []
      },
      {
        "text": "‚Ä¢ Ranelato estroncio: +++\\Nvertebral, ++ cadera",
        "children": []
      },
      {
        "text": "[0: sin evidencia, +: d√©bil, ++:\\Nmoderada, +++: fuerte]",
        "children": []
      },
      {
        "text": "RECOMENDACI√ìN 5:\\NEVALUACI√ìN RIESGO\\NFRACTURA EN OSTEOPENIA",
        "children": []
      },
      {
        "text": "‚Ü≥ Definici√≥n:\\NT-score -1 a -2.5 DS",
        "children": []
      },
      {
        "text": "‚Ü≥ Caracter√≠sticas:",
        "children": []
      },
      {
        "text": "‚Ä¢ Mayor√≠a fracturas fragilidad\\Nocurren en este grupo",
        "children": []
      },
      {
        "text": "‚Ä¢ Mayor√≠a pacientes\\N= riesgo bajo",
        "children": []
      },
      {
        "text": "CRITERIOS\\NTRATAMIENTO:",
        "children": []
      },
      {
        "text": "1. Antecedente\\Nfractura fragilidad:",
        "children": []
      },
      {
        "text": "‚Ä¢ Radiogr√°fica/cl√≠nica",
        "children": []
      },
      {
        "text": "‚Ä¢ Factor riesgo potente",
        "children": []
      },
      {
        "text": "‚Ä¢ Independiente DMO",
        "children": []
      },
      {
        "text": "2. CTx s√©rico:",
        "children": []
      },
      {
        "text": "‚Ä¢ Marcador\\Nresorci√≥n √≥sea",
        "children": []
      },
      {
        "text": "‚Ä¢ ‚Üë = ‚Üëriesgo fractura\\Nposmenopausia",
        "children": []
      },
      {
        "text": "3. FRAX¬Æ:",
        "children": []
      },
      {
        "text": "‚Ä¢ Herramienta OMS",
        "children": []
      },
      {
        "text": "‚Ä¢ Calcula riesgo fractura",
        "children": []
      },
      {
        "text": "‚Ä¢ Limitaci√≥n: solo v√°lido pa√≠ses con\\Ndatos incidencia/mortalidad",
        "children": []
      },
      {
        "text": "‚Ä¢ No validado todas\\Npoblaciones (9)",
        "children": []
      },
      {
        "text": "‚Ä¢ Web: www.shef.\\Nac.uk/FRAX",
        "children": []
      },
      {
        "text": "ALGORITMO\\NDECISI√ìN [Fig\\N17-1]:",
        "children": []
      },
      {
        "text": "‚Ü≥ OSTEOPENIA ‚Üí",
        "children": []
      },
      {
        "text": "1. Fractura fragilidad:",
        "children": []
      },
      {
        "text": "‚Ä¢ S√ç ‚Üí Estudio\\Nb√°sico + tratamiento",
        "children": []
      },
      {
        "text": "‚Ä¢ NO ‚Üí Evaluar\\Nriesgo fractura ‚Üí",
        "children": []
      },
      {
        "text": "- Rx columna ‚Üí",
        "children": []
      },
      {
        "text": "- Evaluar riesgo:",
        "children": []
      },
      {
        "text": "‚Ä¢ S√ç ‚Üí Tratamiento",
        "children": []
      },
      {
        "text": "‚Ä¢ NO ‚Üí CTx:",
        "children": []
      },
      {
        "text": "- Alto ‚Üí Tratamiento",
        "children": []
      },
      {
        "text": "- Normal ‚Üí\\NMedidas\\Ngenerales",
        "children": []
      },
      {
        "text": "VFA (Vertebral\\NFracture Assessment):",
        "children": []
      },
      {
        "text": "‚Ü≥ Concepto:",
        "children": []
      },
      {
        "text": "‚Ä¢ Evaluaci√≥n columna\\Nvertebral v√≠a DXA",
        "children": []
      },
      {
        "text": "‚Ä¢ Prop√≥sito: pesquisa\\Nfracturas vertebrales",
        "children": []
      },
      {
        "text": "‚Ä¢ Ventaja: simult√°neo\\Nmedici√≥n DMO",
        "children": []
      },
      {
        "text": "‚Ä¢ Caracter√≠stica:\\Nbuena sensibilidad",
        "children": []
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\n‚≠ê Ejercicio + nutrici√≥n reduce\\ndiscapacidad en fragilidad f√≠sica\\ncon sarcopenia"
    },
    {
      "id": "map_1668",
      "title": "HORIZON-RFT (2007)\\NHealth Outcomes and Reduced\\NIncidence with Zoledronic Acid\\NOnce Yearly - Recurrent Fracture Trial\\N\\N‚≠ê Zoledronato post fractura cadera\\Nreduce refracturas Y mortalidad"
    },
    {
      "id": "map_1740",
      "title": "FOCUS (2011)\\NFunctional Outcomes in\\NCardiovascular patients\\nUndergoing Surgical\\nhip fracture repair\\N\\n‚≠ê Transfusi√≥n restrictiva (Hb menor 8)\\Nno inferior a liberal (Hb menor 10)\\Nen fractura cadera con riesgo CV"
    },
    {
      "id": "map_1633",
      "title": "ACV: ESCALAS DE UTILIDAD CL√çNICA"
    },
    {
      "id": "map_1671",
      "title": "ICE-FRAIL (2024)\\N\\n‚≠ê Fragilidad predice mortalidad UCI\\N\\nCFS mejor que APACHE/SOFA solos"
    }
  ],
  "source_file": "Arteaga | OSTEOPOROSIS POSMENOPAÃÅUSICA-2024.smmx",
  "created": "2026-02-07T15:42:56.440202"
}